Covered recipient · General Payments record
WALTER J PETERS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,058.72
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $392.97 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $320.34 | 15 |
| Tarsus Pharmaceuticals, Inc. | $50.36 | 2 |
| Ocular Therapeutix, Inc. | $22.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.20 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247622 | CMS |
| ABBVIE INC. | $25.41 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247626 | CMS |
| ABBVIE INC. | $13.81 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247630 | CMS |
| ABBVIE INC. | $30.45 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247634 | CMS |
| ABBVIE INC. | $8.24 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247638 | CMS |
| ABBVIE INC. | $18.92 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247642 | CMS |
| ABBVIE INC. | $28.63 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247646 | CMS |
| ABBVIE INC. | $9.42 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247650 | CMS |
| ABBVIE INC. | $27.20 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247654 | CMS |
| ABBVIE INC. | $25.64 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247658 | CMS |
| ABBVIE INC. | $27.25 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247662 | CMS |
| ABBVIE INC. | $30.38 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247666 | CMS |
| ABBVIE INC. | $8.46 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247671 | CMS |
| ABBVIE INC. | $3.95 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247675 | CMS |
| ABBVIE INC. | $30.38 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105247679 | CMS |
| Ocular Therapeutix, Inc. | $22.27 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148204195 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.18 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139124408 | CMS |
| Tarsus Pharmaceuticals, Inc. | $27.18 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139124410 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.